Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Dietrich

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
JAMA Oncology|August 10, 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJens Huober, Patrik Weder, Karin Ribi, et al.
Archives of Toxicology|October 8, 2016
Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statementRoland Solecki, Andreas Kortenkamp, Åke Bergman, et al.
Archives of Toxicology|August 7, 2021
The EU chemicals strategy for sustainability: in support of the BfR positionFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
JAMA Oncology|August 10, 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJens Huober, Patrik Weder, Karin Ribi, et al.
Archives of Toxicology|October 8, 2016
Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statementRoland Solecki, Andreas Kortenkamp, Åke Bergman, et al.
Archives of Toxicology|August 7, 2021
The EU chemicals strategy for sustainability: in support of the BfR positionFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Pageof 7